EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische Übersicht

Deep learning models to detect neurodegenerative diseases across different modalities, datasets, and stages: A systematic review

Kriti Poddar iD, Charu Wahi iD

Technology and Health Care · 28.10.2026

DOI: 10.1177/09287329261502060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Technology and Health Care, online erschienen am 28.10.2026. Verfasst von Kriti Poddar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science and Engineering, Birla Institute of Technology, Noida, Mesra. Die Arbeit nennt 134 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neurodegenerative diseases like Alzheimer's and Parkinson's pose significant diagnostic challenges because they are incurable. Their symptoms often overlap with those of normal ageing and involve progressive neuronal loss. This makes early prediction, proper diagnosis, and ongoing monitoring crucial at every stage of the disease. Deep learning has become a useful tool for handling different types of data. However, the performance of these models relies heavily on the availability and variety of data, making it important to characterize datasets.

Objective

This PRISMA-based systematic review looks at 111 studies from 2019 to April 2026, organized into three clinical stages of neurodegenerative diseases: early prediction, diagnosis, and progression.

Methods

Each study is assessed across four dimensions: data type (neuroimaging or non-neuroimaging), datasets (open-access, self-created, or hybrid), deep learning model architecture, and the use of explainable AI.

Results

MRI is the only imaging modality that spans all three stages. Speech is the most common non-neuroimaging method for diagnosis, while gait is used only for diagnosis and progression. The ADNI and PPMI datasets are the most commonly used. Self-created datasets introduce new modalities such as ECG and iPSCs, which are not found in open-access datasets. CNNs are the leading models for neuroimaging tasks, while LSTMs and RNNs capture temporal patterns in longitudinal datasets. Survival models are exclusively used for ALS and LATE. Fewer than 6% of the studies used confirmed XAI. Only 2 of the 111 studies validated their results on an independent external cohort.

Conclusion

This review is the only one that covers all three disease stages across multiple neurodegenerative diseases.

Schlagwörter

Stichwörter der Autor:innen

PRISMAdatasetdeep learningdiagnosismodalityneurodegenerative diseaseperformancepredictionpreprocessingprogressionsystematic literature review

Autor:innen und Institutionen

  • Department of Computer Science and Engineering, Birla Institute of Technology, Noida, Mesra.

ORCID-Profile: Kriti Poddar, Charu Wahi

Zitieren

APA

Poddar, K., & Wahi, C. (2026). Deep learning models to detect neurodegenerative diseases across different modalities, datasets, and stages: A systematic review. Technology and Health Care. https://doi.org/10.1177/09287329261502060

Vancouver

Poddar K, Wahi C. Deep learning models to detect neurodegenerative diseases across different modalities, datasets, and stages: A systematic review. Technology and Health Care. 2026. doi:10.1177/09287329261502060

BibTeX
@article{Poddar2026,
  author = {Poddar, Kriti and Wahi, Charu},
  title = {Deep learning models to detect neurodegenerative diseases across different modalities, datasets, and stages: A systematic review},
  journal = {Technology and Health Care},
  year = {2026},
  doi = {10.1177/09287329261502060}
}
Kostenlos starten →